June 19, 2019 Remote Cardiac Monitor Data and Artificial Intelligence: Transforming Clinical Applications for Heart Patients Artificial intelligence has the potential to transform cardiology care, but only time will tell if machine learning’s capabilities will have a widespread impact on outcomes for patients. According to...
May 29, 2019 Wearable Heart Monitors Positioned to Detect Cardiac Anomalies in Athletes Currently available wearable heart rate monitors, such as smart watches, can detect possible cardiac issues where a life-threatening arrhythmia may occur. InfoBionic eyes their technology as a tool to...
March 4, 2019 InfoBionic: Cardiologists Shouldn’t Settle for Incomplete Heart Monitor Reporting On average a patient will have 115,000 heart beats in a day or 1.6M heartbeats in 14 days. Recently, the standard technology for remote cardiac monitoring of patients measured...
January 30, 2019 InfoBionic; Cardiac Monitor Disrupts Current Remote Monitoring with “Full Disclosure Beat-to-Beat” Technology More than 50% of clinically significant cardiac arrhythmias are recorded after the typical 48-hour monitoring period typical for Holter monitors. These legacy monitors rely on the patient to activate...
September 11, 2018 InfoBionic Secures $50 Million in Financing to Support Continued Growth of the MoMe® Kardia System for Cardiac Arrhythmia Detection InfoBionic has announced the completion of a $50 million financing to support continued commercial expansion of its MoMe® Kardia system for remote, wireless outpatient monitoring and diagnosis of cardiac...
August 28, 2018 InfoBionic has Entered into an Exclusive Distributorship with BIOTRONIK for MoMe® Kardia in the U.S.; Expects Significant Nationwide Growth InfoBionic has announced that it has entered into an exclusive distributorship to make BIOTRONIK the exclusive distributor of MoMe® Kardia in the U.S.
February 7, 2018 InfoBionic Exceeds Expectations with Soaring Growth Rates for 2017 as the Company Continues to Disrupt the Traditional Remote Cardiac Monitoring Market with Rapid Adoption of Its MoMe® Kardia System InfoBionic has announced impressive growth rates for 2017, exceeding the company’s projected milestones for the year. The growth was driven by significant market acceptance and adoption of its...
August 22, 2017 InfoBionic Appoints Gene Cattarina to Board of Directors InfoBionic has announced the appointment of Gene Cattarina to its Board of Directors, who brings over 40 years of experience in numerous senior executive positions at companies in healthcare...
August 8, 2017 InfoBionic Announces Rapid Growth, Strong Adoption of Its Market-Shifting Remote Cardiac Arrhythmia Monitoring System InfoBionic has announced significant company growth spurred by rapid adoption of its lead product, MoMe® Kardia, within the strategic markets it has been launched.
April 4, 2017 InfoBionic Names Industry Veteran Stuart Long Chief Executive Officer InfoBionic has announced that Stuart Long was named Chief Executive Officer, underscoring the Company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic...